There are 700 resources available
325P - Losartan plus mFOLFIRINOX versus mFOLFIRINOX in advanced pancreatic adenocarcinomas: A two-arm open label prospective parallel design randomized superiority clinical trial (AFPAC)
Presenter: Vikas Ostwal
Session: Poster Display session
326P - NeoPancONE: Feasibility of completing a neoadjuvant multicentre phase II study in resectable pancreatic ductal adenocarcinoma (r-PDAC), treated with modified FOLFIRINOX (mFFX)
Presenter: Ronan Mclaughlin
Session: Poster Display session
327P - A strategic combination of induction FOLFIRINOX and chemoradiation in locally advanced pancreatic cancer: A phase II trial
Presenter: Michele Fiore
Session: Poster Display session
328P - Trifluridine/tipiracil (FTD/TPI) in patients with fluoropyrimidine refractory advanced pancreatic adenocarcinoma: A single-arm phase II trial
Presenter: Chi Leung Chiang
Session: Poster Display session
329P - Nadunolimab, a first-in-class monoclonal antibody against IL1RAP, in advanced pancreatic cancer
Presenter: Eric Van Cutsem
Session: Poster Display session
330P - Phase I/II clinical study of DFP-17729 as alkalizing agent in patients with metastatic pancreatic cancer
Presenter: Masafumi Ikeda
Session: Poster Display session
331P - Phase Ib/IIa study to evaluate safety and efficacy of priming treatment with the hedgehog inhibitor NLM-001 prior to gemcitabine and nab-paclitaxel plus zalifrelimab as first-line treatment in patients with advanced pancreatic cancer: NUMANTIA study
Presenter: Roberto Pazo Cid
Session: Poster Display session
332P - A phase Ib and pharmacodynamic study of nintedanib monotherapy followed by combination therapy of nintedanib and gemcitabine plus nab-paclitaxel for advanced pancreatic cancer
Presenter: Salwan Al Mutar
Session: Poster Display session
333P - Feasibility and clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling in pancreatic cancer: A systematic review and meta-analysis
Presenter: Seung Bae Yoon
Session: Poster Display session
334P - Prognostic factors for early recurrence after resection of pancreatic cancer: A systematic review and meta-analysis
Presenter: Carl Leonhardt
Session: Poster Display session